Biomarkers Predicting Recurrence and Progression of Ductal Carcinoma In Situ Treated by Lumpectomy Alone

被引：8
|
作者：
Allred, D. Craig [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 09期
关键词：
SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; PROTOCOL B-17; CANCER; TAMOXIFEN; EXPRESSION; PHENOTYPE; DCIS; B-24;
D O I：
10.1093/jnci/djq118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 587
页数：3
相关论文
共 50 条
  • [31] Higher densities of tumour-infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast
    Thike, Aye Aye
    Chen, Xiaoyang
    Koh, Valerie Cui Yun
    Binte Md Nasir, Nur Diyana
    Yeong, Joe P. S.
    Bay, Boon Huat
    Tan, Puay Hoon
    HISTOPATHOLOGY, 2020, 76 (06) : 852 - 864
  • [32] Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: Clinical outcome
    Cox, CE
    Hyacinthe, M
    Gonzalez, RJ
    Lyman, G
    Reintgen, D
    Ku, NN
    Miller, MS
    Greenberg, H
    Nicosia, SV
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (08) : 644 - 649
  • [33] Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy
    Molinaro, Annette M.
    Sison, Jennette D.
    Ljung, Britt-Marie
    Tlsty, Thea D.
    Kerlikowske, Karla
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 351 - 361
  • [34] Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview
    Chiorescu, Amelia
    Fredholm, Hanna
    Sackey, Helena Ikonomidis
    Fredriksson, Irma
    CHIRURGIA, 2021, 116 (05) : S128 - S135
  • [35] AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ
    Yoon, Jiyoung
    Yang, Juyeon
    Lee, Hye Sun
    Kim, Min Jung
    Park, Vivian Youngjean
    Rho, Miribi
    Yoon, Jung Hyun
    INSIGHTS INTO IMAGING, 2024, 15 (01)
  • [36] Ductal carcinoma in situ treated with radiation therapy and additional boost
    Geiss, R.
    Cabel, L.
    Touboul, E.
    Lefranc, J. P.
    Darai, E.
    Lauratet, B.
    Monnier, L.
    Haberer-Guillerm, S.
    Deluen, F.
    Schlienger, M.
    Huguet, F.
    CANCER RADIOTHERAPIE, 2015, 19 (03): : 175 - 179
  • [37] Predictors of Recurrence in Patients Diagnosed with Ductal Carcinoma In Situ
    Sue, Gloria R.
    Chagpar, Anees B.
    AMERICAN SURGEON, 2015, 81 (01) : 48 - 51
  • [38] Individualized Local Recurrence Estimates for Ductal Carcinoma In Situ
    Warren, Laura E. G.
    Bellon, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (27)
  • [39] A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
    Bremer, Troy
    Whitworth, Pat W.
    Patel, Rakesh
    Savala, Jess
    Barry, Todd
    Lyle, Stephen
    Leesman, Glen
    Linke, Steven P.
    Jirstrom, Karin
    Zhou, Wenjing
    Amini, Rose-Marie
    Warnberg, Fredrik
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5895 - 5901
  • [40] Ductal Carcinoma in situ of the Breast in Israeli Women Treated by Breast-Conserving Surgery Followed by Radiation Therapy
    Jiveliouk, Irina
    Corn, Benjamin
    Inbar, Moshe
    Merimsky, Ofer
    ONCOLOGY, 2009, 76 (01) : 30 - 35
12345